InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-8.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Coleman Glenn, Chief Executive Officer. Officer active across 4 companies, notably Integra Lifesciences Holdings CORP. Cumulatively, 27 reports have been recorded. Split: 1 buy · 2 sells. Total volume traded: €922k. History available since 2 November 2021. The latest transaction was disclosed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Coleman Glenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
6,640 shares@ US$180.710.014% mcap100.0% of flowCommon StockSEC:0001100682-26-000101:0
161,464 shares@ US$28.2590.5% of flowClass A Common StockSEC:0001193125-25-299012:0
17,026 shares@ US$28.17100.0% of flowClass A Common StockSEC:0001193125-25-277429:0
32,018 shares0Class A Common StockSEC:0001434369-25-000003:0
15,001 shares0Class A Common StockSEC:0000950170-25-110504:0
143,475 shares0Class A Common StockSEC:0000950170-24-125221:0
375.279 shares0Common StockSEC:0001127602-24-025499:0
404.918 shares0Common StockSEC:0001127602-24-020387:0
302.443 shares0Common StockSEC:0001127602-24-012897:0
18,780 shares0Common StockSEC:0001127602-24-008823:0
1,683 shares@ US$33.2711.3% of flowCommon StockSEC:0001127602-24-008222:0
193.629 shares0Common StockSEC:0001127602-24-001307:0
2,461 shares@ US$31.3615.4% of flowCommon StockSEC:0001127602-23-028287:0
10,000 shares@ US$29.7059.3% of flowCommon StockSEC:0001127602-23-027984:0
Canonical exit: 18 Feb 2024 (T+90)
2,385 shares@ US$29.3214.0% of flowCommon StockSEC:0001127602-23-027596:0
268.072 shares0Common StockSEC:0001127602-23-025907:0
228.02 shares0Common StockSEC:0001127602-23-020823:0
231.492 shares0Common StockSEC:0001127602-23-013135:0
16,133 shares0Common StockSEC:0001127602-23-009277:0
378.801 shares0Common StockSEC:0001127602-23-001395:0
24,695 shares0Common StockSEC:0001127602-22-026304:0
23,931 shares0Common StockSEC:0001127602-22-025939:0
6,666 shares@ US$55.0027.5% of flowCommon StockSEC:0001209191-22-040765:0
6,268 shares@ US$66.040.039% mcap40.9% of flowCommon StockSEC:0001209191-22-023469:0
7,119 shares0Common StockSEC:0001209191-22-018845:0
25 of 27 declarations
About Coleman Glenn
Glenn Coleman is the Chief Executive Officer and Executive Vice President & COO of Integra LifeSciences Holdings Corp. He oversees the strategic operations of the company and plays a key role in driving growth initiatives. His leadership is crucial in achieving the company's objectives in the life sciences sector.
